SCHEMBL23225679

SCHEMBL23225679

C=CCC(C)(C)C(=O)OCn1ccc2c1c(=O)n(COC(=O)C(C)(C)CC)c(=S)n2CCOC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23218019 0.97 OPRM1 (0.32) —
SCHEMBL27103673 0.94 — —
SCHEMBL27144508 0.87 — —
SCHEMBL23217963 0.85 POLB (0.38) —
SCHEMBL23225706 0.80 POLB (0.34) —
SCHEMBL23225714 0.80 OPRM1 (0.48) —
SCHEMBL23225604 0.78 MPO (0.35) —
SCHEMBL27103572 0.76 OPRM1 (0.32) —
SCHEMBL27102076 0.75 KDM4E (0.31) —
SCHEMBL23225722 0.75 OPRM1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072140-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. (US) 2021-04-15 — — WO disclosed
Send feedback